切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2020, Vol. 14 ›› Issue (03) : 219 -224. doi: 10.3877/cma.j.issn.1674-3253.2020.03.015

所属专题: 经典病例 经典病例 文献

病例研究

三例肾脏原发少见肿瘤的临床特征及诊治分析
杨祥伟1, 黄儒1, 卢晓芳2, 廖国龙1, 熊海云1, 严彬元1, 唐嘉妮1, 陈楚杰1, 庞俊1, 史复1,()   
  1. 1. 518107 深圳,中山大学附属第七医院泌尿外科
    2. 518107 深圳,中山大学附属第七医院病理科
  • 收稿日期:2019-01-04 出版日期:2020-06-01
  • 通信作者: 史复
  • 基金资助:
    国家自然科学基金面上项目(81772754)

The clinical features, diagnosis and treatment of 3 cases of primary rare kidney neoplasms

Xiangwei Yang1, Ru Huang1, Xiaofang Lu2, Guolong Liao1, Haiyun Xiong1, Binyuan Yan1, Jiani Tang1, Chujie Chen1, Jun Pang1, Fu Shi1,()   

  1. 1. Department of Urology, the Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, China
    2. Department of Pathology, the Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, China
  • Received:2019-01-04 Published:2020-06-01
  • Corresponding author: Fu Shi
  • About author:
    Corresponding author: Shi Fu, Email:
引用本文:

杨祥伟, 黄儒, 卢晓芳, 廖国龙, 熊海云, 严彬元, 唐嘉妮, 陈楚杰, 庞俊, 史复. 三例肾脏原发少见肿瘤的临床特征及诊治分析[J]. 中华腔镜泌尿外科杂志(电子版), 2020, 14(03): 219-224.

Xiangwei Yang, Ru Huang, Xiaofang Lu, Guolong Liao, Haiyun Xiong, Binyuan Yan, Jiani Tang, Chujie Chen, Jun Pang, Fu Shi. The clinical features, diagnosis and treatment of 3 cases of primary rare kidney neoplasms[J]. Chinese Journal of Endourology(Electronic Edition), 2020, 14(03): 219-224.

目的

总结分析3例肾脏原发少见肿瘤的临床特征及诊治方法,提高对肾脏原发少见肿瘤的认识。

方法

回顾性分析2018年5月至9月于中山大学附属第七医院泌尿外科诊治的术后病理证实的3例肾脏原发少见肿瘤的临床资料。

结果

3例患者分别为:(1)54岁女性,因体检发现左肾占位1周入院,CT提示左肾巨大软组织肿块及肾门多个肿大淋巴结,行腹腔镜下根治性左肾切除术+淋巴结清扫术,术后病理:肾黏液管状与梭形细胞癌,术后3个月随访肿瘤无复发转移;(2)44岁男性,因左侧腰腹部胀痛1个月入院,MR提示左肾巨大占位病变,开放探查见肿瘤与降结肠粘连明显,遂行根治性左肾切除+降结肠部分切除术,术后病理:肾脏癌肉瘤,术后1个月局部复发并腹腔内多发转移,入肿瘤内科后辅以紫杉醇+多柔比星化疗及阿帕替尼靶向治疗,目前未观察到肿瘤继续恶化;(3)70岁男性,因左侧腰痛伴肉眼血尿3个月入院,CT提示左肾上极不规则低密度灶及腹膜后多发肿大淋巴结,行腹腔镜下根治性左肾切除+淋巴结清扫术,术后病理:高级别浸润性尿路上皮癌,拟二次手术,患者拒绝,术后6个月随访肿瘤无复发转移。

结论

肾脏原发少见肿瘤临床症状及影像学表现常无明显特异性,容易误诊,应注意鉴别诊断,治疗以根治性切除为主,部分肿瘤预后不良,术后需密切随访,必要时尽早辅以放化疗及靶向治疗。

Objective

To analyze the clinical characteristics and methods of diagnosis and treatment of primary rare kidney neoplasms, in order to improve the understanding of primary rare kidney neoplasms.

Methods

The data of three cases of primary rare kidney neoplasms confirmed pathologically in the Seventh Affiliated Hospital of Sun Yat-sen University from May 2018 to September 2018 were analyzed retrospectively.

Results

Case 1 was a 54-year-old woman, CT scan showed a large soft tissue mass in the left kidney and several enlarged lymph nodes around renal hilum in a routine check-up a week ago, laparoscopic radical left nephrectomy and lymphadenectomy were then conducted and the mass was pathologically proved to be mucinous tubular and spindle cell carcinoma, no recurrence or metastasis was observed during a 3-month follow-up. Case 2 was a 44-year-old man, presented with a 1-month history of left flank abdominal pain, MR examination revealed a huge space-occupying lesion in the left kidney. In consideration of inconvenient laparoscopic operation, open exploratory surgery was performed. During the operation the descending colon was discovered adhered to the lesion apparently, consequently radical left nephrectomy and partial resection of descending colon were conducted, and the histopathology was proved to be carcinosarcoma. Local relapse and extensive intraperitoneal metastasis were observed a month later, auxiliary chemotherapy with paclitaxel combined doxorubicin and targeted therapy with apatinib were executed according to oncologist’s advices, no further progression was observed till now. Case 3 was a 70-year-old man, presented with left flank pain and gross hematuria for three months, CT scan displayed irregular low-density focus in the upper pole of the left kidney and multiple retroperitoneal enlarged lymph nodes. Laparoscopic radical left nephrectomy and lymphadenectomy were carried out and the histopathology was unexpectedly proved to be high grade invasive urothelial carcinoma, the further nephroureterectomy was recommended but the patient refused it, neither recurrence nor metastasis was observed during a 6-month follow-up.

Conclusion

The clinical symptoms and imaging manifestations of primary rare kidney neoplasms are frequently lack of specific and easily to be misdiagnosed, more attention should be paid to distinguish from other diseases. Radical excision is the main therapeutic method, some types of neoplasms have a poor prognosis and close follow-up is essential, auxiliary radiotherapy, chemotherapy or targeted therapy should be performed postoperatively as early as possible if it is necessary.

图3 3例患者术后病理资料
[19]
Babjuk M, Burger M, Compérat E, et al. EAU Guidelines on Non-muscle-invasive Bladder Cancer (T1, T1 and CIS), in EAU Guidelines, Edn. presented at the 34th EAU Annual Congress Barcelona[EB/OL]. 2019, EAU Guidelines Office.

URL    
[20]
Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades[J]. J Urol, 2000, 164(5): 1523-1525.
[21]
Shariat SF, Favaretto RL, Gupta A, et al. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma[J]. World J Urol, 2011, 29(4): 481-486.
[22]
Browne R F J, Meehan C P, Colville J, et al. Transitional cell carcinoma of the upper urinary tract: spectrum of imaging findings[J]. Radiographics, 2005, 25(6): 1609-1627.
[23]
Tawfiek E R, Bagley D H. Upper-tract transitional cell carcinoma[J]. Urology, 1997, 50(3): 321-329.
[24]
Gunia S, Erbersdobler A, Koch S, et al. Protein gene product 9.5 is diagnostically helpful in delineating high-grade renal cell cancer involving the renal medullary/sinus region from invasive urothelial cell carcinoma of the renal pelvis[J]. Hum Pathol, 2013, 44(5): 712-717.
[25]
Abouassaly R, Alibhai S MH, Shah N, et al. Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma[J]. Urology, 2010, 76(4): 895-901.
[26]
Jeldres C, Sun M, Isbarn H, et al. A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma[J]. Urology, 2010, 75(2): 315-320.
[27]
Crivelli J J, Xylinas E, Kluth L A, et al. Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature[J]. Eur Urol, 2014, 65(4): 742-754.
[1]
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017[J]. CA Cancer J Clin, 2017, 67(1): 7-30.
[2]
Choueiri T K, Motzer R J. Systemic therapy for metastatic renal-cell carcinoma[J]. N Engl J Med, 2017, 376(4): 354-366.
[3]
Moch H, Cubilla AL, Humphrey PA, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours[J]. Eur Urol, 2016, 70(1): 93-105.
[4]
Capitanio U, Cloutier V, Zini L, et al. A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study[J]. BJU int, 2009, 103(11): 1496-1500.
[5]
Guinan P, Vogelzang NJ, Randazzo R, et al. Renal pelvic cancer: a review of 611 patients treated in Illinois 1975-1985[J]. Urology, 1992, 40(5): 393-399.
[6]
Lopez-Beltran A, Scarpelli M, Montironi R, et al. 2004 WHO classification of the renal tumors of the adults[J]. Eur Urol, 2006, 49(5): 798-805.
[7]
Zhao M, He X, Teng X. Mucinous tubular and spindle cell renal cell carcinoma: a review of clinicopathologic aspects[J]. Diagn Pathol, 2015, 10(1): 168.
[8]
Yang G, Breyer B N, Weiss D A, et al. Mucinous tubular and spindle cell carcinoma of the kidney[J]. J Urol, 2010, 183(2): 738.
[9]
Zhu Q, Zhu W, Wang Z, et al. Clinical and CT imaging features of mucinous tubular and spindle cell carcinoma[J]. Chin Med J(Engl), 2014, 127(7): 1278-1283.
[10]
Srigley JR, Delahunt B, Eble JN, et al. The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia[J]. Am J Surg Pathol, 2013, 37(10): 1469-1489.
[11]
Reuter V E, Argani P, Zhou M, et al. Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference[J]. Am J Surg Pathol, 2014, 38(8): e35-e49.
[12]
Kenney P A, Vikram R, Prasad S R, et al. Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: a detailed study of radiological, pathological and clinical outcomes[J]. BJU int, 2015, 116(1): 85-92.
[13]
Cornelis F, Ambrosetti D, Rocher L, et al. CT and MR imaging features of mucinous tubular and spindle cell carcinoma of the kidneys. A multi-institutional review[J]. Eur Radiol, 2017, 27(3): 1087-1095.
[14]
Dimitriou R J, Gattuso P, Coogan CL. Carcinosarcoma of the renal pelvis[J]. Urology, 2000, 56(3): 508.
[15]
Lopez-Beltran A, Montironi R, Carazo JL, et al. Primary renal osteosarcoma[J]. Am J Clin Pathol, 2014, 141(5): 747-752.
[16]
邝菲, 钟群, 聂枚. 肾脏癌肉瘤的影像表现[J]. 临床放射学杂志, 2010, 29(10): 1356-1359.
[17]
田溪泉, 邢念增. 肾脏癌肉瘤和肉瘤样癌的病理及临床特点[J]. 临床泌尿外科杂志, 2008, 23(8): 584-586.
[18]
Abu-Khalaf M M, Raza M A, Hatzis C, et al. Efficacy and tolerability of combination cisplatin and ifosfamide chemotherapy with vaginal cuff brachytherapy in the first line treatment of uterine carcinosarcoma[J]. Eur J Gynaecol oncol, 2016, 37(2): 199-203.
[1] 汪洋, 李志鹏, 王可兵. 上尿路尿路上皮癌术后预防性膀胱灌注化疗的研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 649-652.
[2] 赵佳晖, 王永兴, 彭涛, 李明川, 魏德超, 韩毅力, 侯铸, 姜永光, 罗勇. 后腹腔镜根治性肾切除手术时间延长和术中出血量增多的影响因素分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 575-580.
[3] 熊风, 林辉煌, 陈晓波. 铥激光在泌尿外科中的临床应用及研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 533-536.
[4] 余俊豪, 麻立. 经腹全腹腔镜上尿路尿路上皮癌根治术在临床中的应用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 529-532.
[5] 康海, 谭武宾, 周松, 毛正, 米泽振, 李铁求. 膀胱癌根治术后阴茎转移一例报告[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 523-525.
[6] 李国良, 吴凡, 李浩民, 江俊斌, 郭泽雄, 卓育敏, 马鑫, 赖彩永. 抽栓技术在完全腹腔镜左肾癌合并Ⅳ级腔静脉癌栓取出术的应用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 403-406.
[7] 董翔, 马文亮, 纪长威, 李笑弓, 张古田, 甘卫东, 郭宏骞. 回顾性评估肾细胞癌假包膜状态及其影响因素[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 356-360.
[8] 刘麒, 曾弘, 徐子昕, 方超, 黄铭, 郑俊炯, 吴少旭, 钟广正, 林天歆, 黄健, 董文. 乳头状肾细胞癌单中心11年临床诊治与预后分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 351-355.
[9] 刘阳阳, 王梁, 戴志红, 郝建戈, 张力仁, 刘志宇. 腹膜后去分化脂肪肉瘤合并左肾透明细胞癌一例报告[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 412-414.
[10] 杨春亭, 毛云华, 罗云, 刘博皓. 孤立肾合并肾混合性上皮间质肿瘤一例报告并文献复习[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 407-409.
[11] 陈伟, 周骏, 梁朝朝. 机器人辅助腹腔镜下右肾部分切除术治疗后肾腺瘤一例报告[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 293-293,298.
[12] 唐国军, 洪余德, 赵崇玉, 李辽源. 基于TCGA数据库Wnt相关长链非编码RNA构建肾乳头状细胞癌预后模型[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 270-275.
[13] 卓然, 朱逸琪, 逯艳文, 马文亮, 郭宏骞, 甘卫东. 性别对Xp11.2易位型肾癌及肾透明细胞癌临床特征的影响[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(02): 105-109.
[14] 周硕明, 甘卫东. 2022版欧洲泌尿外科学会肾细胞癌诊疗指南更新要点解读[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(02): 100-104.
[15] 朱嘉宁, 赵萍, 李楠, 朱连华, 李静波, 罗渝昆, 李秋洋. 术前及术中超声在最大径≤1.5 cm小肾肿瘤中的临床应用研究[J]. 中华肾病研究电子杂志, 2023, 12(01): 20-25.
阅读次数
全文


摘要